All practice questions

Question 261Question →

A 42-year-old woman is brought to the emergency department by her husband due to a 24-hour history of severe headache, high fever, and worsening confusion. Her medical history is significant for a recent kidney transplant, for which she takes immunosuppressive medications. Her temperature is 39.2°C (102.6°F). Physical examination demonstrates marked nuchal rigidity and a new left lower extremity weakness. Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for managing this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Obtain blood cultures, followed by administration of empiric intravenous antibiotics and dexamethasone, then perform a CT scan of the head, and finally perform a lumbar puncture.

In patients with suspected bacterial meningitis who have indications for a CT scan prior to a lumbar puncture (such as immunosuppression, focal neurologic deficits, papilledema, or altered mental status), the correct management sequence is to first obtain blood cultures, immediately administer empiric antibiotics and dexamethasone, perform the CT scan of the head to rule out mass effect, and finally perform the lumbar puncture. This sequence ensures life-saving therapy is not delayed while preventing the risk of brain herniation.

Step-by-Step Solution

1

Identify the suspected diagnosis and critical patient characteristics.

The patient has signs of bacterial meningitis (fever, headache, nuchal rigidity) along with indications for neuroimaging before a lumbar puncture (immunosuppressive medication use, altered mental status, and a focal neurologic deficit).

Certain patient characteristics dictate a change in the standard diagnostic algorithm to prevent complications like brain herniation.

2

Determine the first step in management.

Blood cultures must be obtained immediately.

Cultures should ideally be drawn before antibiotic administration to ensure pathogen recovery, without delaying necessary life-saving therapy.

3

Determine the timing of antibiotic therapy.

Empiric intravenous antibiotics and dexamethasone are administered immediately after blood cultures are drawn.

Because the lumbar puncture will be delayed by the need for a CT scan, antibiotics cannot wait. Delaying antibiotics in bacterial meningitis increases mortality.

4

Sequence the neuroimaging and definitive diagnostic procedure.

A CT scan of the head is performed, followed by a lumbar puncture.

The CT scan must rule out a space-occupying lesion first. Once cleared, the lumbar puncture is safely performed to analyze the cerebrospinal fluid.

Key Concept

Management sequence for suspected bacterial meningitis when cranial imaging is indicated before lumbar puncture

Question 262Question →

A 24-year-old man is diagnosed with active ankylosing spondylitis characterized by progressive inflammatory back pain, elevated inflammatory markers, and severe morning stiffness. Arrange the following therapeutic interventions in the standard chronological sequence for escalating disease management, from initial first-line therapy to end-stage treatment.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing ankylosing spondylitis escalates from continuous NSAIDs, to a TNF-alpha inhibitor, then to an IL-17 inhibitor if the first biologic fails, and finally to surgery for end-stage structural damage.

The standard management pathway for ankylosing spondylitis (AS) strictly follows a step-up approach. Initial management relies on continuous NSAIDs, which effectively control symptoms and are the cornerstone of early therapy. When patients have refractory symptoms or objectively high disease activity despite an adequate NSAID trial, escalation to a biologic DMARD, typically a TNF-alpha inhibitor, is indicated. If primary non-response or secondary loss of response occurs with the first biologic, switching to a different class, such as an IL-17 inhibitor, is the next logical pharmacological step. Finally, surgical interventions (e.g., spinal osteotomy) are reserved as a last resort for severe complications of advanced structural disease.

Step-by-Step Solution

1

Identify the first-line therapy for active ankylosing spondylitis.

Continuous NSAIDs are established as the initial pharmacological treatment.

NSAIDs provide significant symptom relief and may slow radiographic progression in early axial disease.

2

Determine the escalation step for NSAID-refractory disease.

A TNF-alpha inhibitor is added.

When NSAIDs fail to control disease activity, guidelines recommend escalating directly to a biologic agent, most commonly a TNF inhibitor.

3

Determine the alternative medical therapy if the initial biologic fails.

An IL-17 inhibitor is substituted.

If primary non-response or secondary loss of response occurs with a TNF inhibitor, switching to a different biologic mechanism (like an IL-17 inhibitor) is indicated.

4

Identify the treatment for refractory, end-stage structural complications.

Corrective spinal surgery or joint arthroplasty.

Once irreversible structural damage occurs that severely impairs quality of life or causes neurological deficits, surgical intervention becomes necessary.

Key Concept

Step-up pharmacological and surgical management pathway for ankylosing spondylitis.

Estimated Time:1m 0s

Question 263Question →

A clinic evaluates a 55-year-old male who developed sudden, severe right knee swelling and pain 48 hours ago. He denies any recent trauma, falls, or prior joint issues. His current temperature is 38.2°C (100.8°F). Examination reveals a visibly enlarged, erythematous right knee that is exquisitely tender to palpation. Range of motion is severely limited by pain. Which of the following is the most appropriate initial step in the evaluation of this patient?

Measurement of serum uric acid concentration

Initiation of empiric intravenous vancomycin and ceftriaxone

Arthrocentesis and synovial fluid analysis

Magnetic resonance imaging of the right knee

Intra-articular injection of a long-acting glucocorticoid

Show answer & explanation

Answer: Arthrocentesis and synovial fluid analysis

Answer

Arthrocentesis and synovial fluid analysis

The patient presents with an acute, atraumatic, inflammatory monoarthritis accompanied by systemic signs (fever). This clinical picture is highly suspicious for septic arthritis, which is a joint-threatening medical emergency, as well as acute crystal arthropathy (such as gout or pseudogout). The most critical and urgent initial step is to perform arthrocentesis and synovial fluid analysis (including cell count, Gram stain, and crystal analysis). This procedure definitively establishes the diagnosis and rules out a bacterial infection, which dictates the subsequent course of management.

Step-by-Step Solution

1

Identify the primary clinical syndrome based on the patient's presentation.

The patient has an acute, atraumatic monoarticular arthritis accompanied by fever.

Recognizing the pattern of acute monoarthritis is the first step in formulating a differential diagnosis, which primarily includes septic arthritis, gout, and pseudogout.

2

Determine the most critical, time-sensitive condition to rule out.

Septic arthritis is a medical emergency that must be rapidly identified or excluded.

Failure to diagnose and treat a septic joint can lead to irreversible joint destruction within days and carries significant morbidity.

3

Select the appropriate diagnostic modality to differentiate the possible etiologies.

Arthrocentesis with synovial fluid analysis is the definitive test.

Direct examination of the synovial fluid allows for the immediate identification of crystals (diagnosing gout/pseudogout) or microorganisms and elevated leukocytes (diagnosing infection).

Key Concept

The initial evaluation of any acute, inflammatory monoarthritis must always include arthrocentesis to definitively rule out septic arthritis before initiating specific treatments.

Question 264Question →

A 64-year-old woman is brought to the emergency department by her son due to worsening confusion, nausea, and ringing in her ears for the past 24 hours. She has a history of chronic obstructive pulmonary disease (COPD), hypertension, and osteoarthritis, for which she frequently takes over-the-counter analgesics. She also underwent transsphenoidal resection of a pituitary macroadenoma 5 years ago.

Vital signs: Temperature 37.1°C (98.8°F), blood pressure 110/70 mmHg, heart rate 112/min, respiratory rate 28/min.

Physical examination reveals dry mucous membranes and lethargy. Lung auscultation reveals clear breath sounds bilaterally. There is no jugular venous distention.

Laboratory results:
Sodium: 141 mEq/L
Potassium: 3.9 mEq/L
Chloride: 105 mEq/L
Bicarbonate: 14 mEq/L
Blood urea nitrogen: 38 mg/dL
Creatinine: 1.8 mg/dL
Thyroid-stimulating hormone (TSH): 1.1 µU/mL (normal: 0.4–4.0 µU/mL)
Free T4: 0.5 ng/dL (normal: 0.9–1.7 ng/dL)

Arterial blood gas on room air:
pH: 7.42
$PaCO_2$ : 22 mmHg
$PaO_2$ : 96 mmHg

A urine culture sent 3 days ago from an outpatient clinic visit for mild dysuria has returned positive for $>100,000$ CFU/mL of *Escherichia coli*, which is susceptible to cephalexin and nitrofurantoin, but resistant to fluoroquinolones.

Which of the following is the most appropriate next step in management?

Intravenous sodium bicarbonate

Intravenous 0.9% normal saline and observation

Intravenous furosemide

Intravenous piperacillin-tazobactam

Initiation of levothyroxine

Show answer & explanation

Answer: Intravenous sodium bicarbonate

Answer

Intravenous sodium bicarbonate

The correct intervention is intravenous sodium bicarbonate. This patient presents with characteristic features of salicylate (aspirin) toxicity, specifically tinnitus, nausea, tachypnea, and altered mental status. Salicylates cause a classic mixed acid-base disorder. They directly stimulate the medullary respiratory center, causing hyperventilation and a primary respiratory alkalosis. Simultaneously, they uncouple oxidative phosphorylation, leading to the accumulation of unmeasured organic acids and a primary high anion gap metabolic acidosis (AG =

141 - (105 + 14) = 22

). Winter's formula shows an expected

PaCO_2

of

29 \pm 2

mmHg; the measured

PaCO_2

of 22 mmHg confirms a concomitant primary respiratory alkalosis. The near-normal pH of 7.42 is a typical feature of this mixed disorder. Treatment focuses on stabilizing the patient and alkalinizing the urine with continuous intravenous sodium bicarbonate. Alkalinization converts salicylic acid into its ionized, lipophobic form in the renal tubules, trapping it in the urine and significantly enhancing its excretion.

Step-by-Step Solution

1

Analyze the acid-base status using the provided arterial blood gas and basic metabolic panel.

The anion gap is calculated as

141 - (105 + 14) = 22

mEq/L, indicating a primary high anion gap metabolic acidosis. The pH is unexpectedly normal (7.42).

Determining the primary disorder and calculating the anion gap are the first steps in evaluating any acid-base derangement.

2

Calculate expected respiratory compensation using Winter's formula.

Expected

PaCO_2 = 1.5 \times 14 + 8 \pm 2 = 29 \pm 2

mmHg. The actual

PaCO_2

is 22 mmHg, which is significantly lower than expected.

If the measured

PaCO_2

falls outside the expected range, a secondary primary acid-base disorder is present. In this case, there is a concurrent primary respiratory alkalosis.

3

Correlate the mixed acid-base disorder with the clinical presentation.

A mixed high anion gap metabolic acidosis and primary respiratory alkalosis in a patient with tinnitus (ringing in ears) points to salicylate (aspirin) toxicity.

Salicylates directly stimulate the medullary respiratory center (respiratory alkalosis) and uncouple oxidative phosphorylation, leading to the accumulation of organic acids (metabolic acidosis).

4

Determine the definitive treatment for the identified toxicity.

Administration of intravenous sodium bicarbonate is required.

Sodium bicarbonate alkalinizes the blood and urine. Alkalemia promotes the movement of salicylates out of the central nervous system, while alkalinized urine traps the ionized form of salicylate, accelerating its excretion.

Key Concept

Patients with severe salicylate toxicity classically present with a mixed primary respiratory alkalosis and primary high anion gap metabolic acidosis. Treatment includes intravenous sodium bicarbonate to alkalinize the urine and enhance salicylate excretion.

Estimated Time:1m 30s

Question 265Question →

A $19$ -year-old male of Mediterranean descent is admitted to the hospital with newly diagnosed Burkitt lymphoma. He has a massive abdominal tumor burden. Baseline laboratory studies reveal a serum uric acid level of $14.2 \text{ mg/dL}$ and a serum creatinine of $1.9 \text{ mg/dL}$ . To mitigate the risk of tumor lysis syndrome, he receives aggressive intravenous hydration and a dose of rasburicase. Forty-eight hours later, the patient acutely develops shortness of breath, fatigue, and bluish discoloration of his lips and fingertips. Vital signs are: temperature $37.1^\circ \text{C}$ , heart rate $128$ /min, blood pressure $105/65$ mmHg, and respiratory rate $28$ /min. Pulse oximetry shows an oxygen saturation of $84\%$ on room air, which does not improve following the administration of $100\%$ oxygen via a non-rebreather mask. Arterial blood gas on $100\%$ oxygen shows a PaO $_2$ of $410$ mmHg. Blood drawn from the patient's vein appears chocolate-brown. Laboratory studies show a rapid decline in hemoglobin from $14.5 \text{ g/dL}$ to $8.2 \text{ g/dL}$ . A peripheral blood smear reveals numerous bite cells and Heinz bodies. Which of the following is the most appropriate next step in the management of this patient's acute respiratory compromise?

Perform red blood cell exchange transfusion

Administer intravenous methylene blue

Administer intravenous ascorbic acid

Initiate therapeutic enoxaparin and order a CT pulmonary angiography

Transfuse two units of packed red blood cells

Show answer & explanation

Answer: Perform red blood cell exchange transfusion

Answer

Perform red blood cell exchange transfusion

The correct answer is to perform a red blood cell exchange transfusion. This patient has developed acute severe methemoglobinemia and hemolytic anemia secondary to rasburicase administration. Rasburicase is a recombinant urate oxidase used to prevent tumor lysis syndrome by converting uric acid to allantoin. This reaction generates large amounts of hydrogen peroxide (

H_2O_2

) as a byproduct. In patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency (suggested by his Mediterranean descent and the presence of bite cells and Heinz bodies on the blood smear), the inability to generate NADPH renders erythrocytes highly susceptible to oxidative stress. This stress simultaneously causes hemolysis and oxidizes normal ferrous hemoglobin (Fe

^{2+}

) to ferric methemoglobin (Fe

^{3+}

). Methemoglobinemia is characterized by central cyanosis, a 'saturation gap' (low pulse oximetry reading despite a high PaO

_2

on arterial blood gas), and chocolate-brown blood. While methylene blue is the standard first-line treatment for methemoglobinemia, its mechanism of action requires NADPH from the G6PD pathway. In G6PD-deficient patients, methylene blue is not only ineffective but also acts as a potent exogenous oxidant, precipitating a potentially fatal hemolytic crisis. Therefore, severe symptomatic methemoglobinemia in a G6PD-deficient patient must be managed with a red blood cell exchange transfusion (or hyperbaric oxygen therapy) to physically remove the methemoglobin and replace it with functional red blood cells.

Step-by-Step Solution

1

Analyze the patient's history and peripheral blood smear.

The presence of bite cells, Heinz bodies, and Mediterranean descent in the context of an oxidative trigger confirms underlying glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Identifying this underlying enzyme deficiency is critical, as it fundamentally alters the safety profile of subsequent therapeutic interventions.

2

Interpret the oxygenation paradox and distinct clinical signs.

A persistently low pulse oximetry reading despite a very high PaO2 (a 'saturation gap'), accompanied by central cyanosis and chocolate-brown blood, confirms the diagnosis of severe methemoglobinemia.

Rasburicase (a recombinant urate oxidase) catalyzed the breakdown of uric acid into allantoin and hydrogen peroxide. The accumulated hydrogen peroxide caused massive oxidative stress, leading to both hemolysis and the oxidation of hemoglobin to methemoglobin.

3

Select the appropriate therapy for methemoglobinemia based on the patient's G6PD status.

Red blood cell exchange transfusion is chosen as the definitive intervention.

The standard first-line treatment, methylene blue, requires the G6PD-dependent production of NADPH to reduce methemoglobin. In G6PD deficiency, methylene blue is ineffective and acts as a dangerous oxidant, while exchange transfusion safely removes the defective erythrocytes.

Key Concept

Patients with G6PD deficiency who develop severe, symptomatic methemoglobinemia (e.g., secondary to rasburicase-induced oxidative stress) must be treated with exchange transfusion or hyperbaric oxygen, as methylene blue is strictly contraindicated.

Question 266Question →

Match each patient scenario describing the initiation of a specific targeted biologic or immunomodulatory therapy with the most appropriate infectious disease screening or prophylactic management step.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Alemtuzumab pairs with TMP-SMX/acyclovir prophylaxis; Infliximab pairs with tuberculosis screening; Rituximab pairs with Hepatitis B screening; Eculizumab pairs with meningococcal vaccination.

Modern immunomodulatory therapies create specific, predictable infectious vulnerabilities based on their molecular targets. Understanding the mechanism of action of each biologic is essential for implementing the correct pre-treatment screening and prophylactic regimens to prevent severe iatrogenic complications.

Step-by-Step Solution

1

Analyze the mechanism of action of alemtuzumab.

Identified as an anti-CD52 antibody causing profound and prolonged lymphopenia.

This predicts susceptibility to cellular immunity pathogens like P. jirovecii and herpesviruses, requiring specific prophylaxis.

2

Analyze the mechanism of action of infliximab.

Identified as a TNF-alpha inhibitor.

TNF-alpha is required for granuloma maintenance; its inhibition risks tuberculosis reactivation, mandating prior IGRA or TST screening.

3

Analyze the mechanism of action of rituximab.

Identified as a CD20-depleting antibody.

B-cell depletion poses a severe risk of Hepatitis B virus reactivation (even from a resolved prior infection), mandating HBsAg and anti-HBc screening.

4

Analyze the mechanism of action of eculizumab.

Identified as a C5 complement inhibitor.

The terminal complement (membrane attack complex) is essential for clearing Neisseria meningitidis, mandating vaccination and potential continuous antibiotic prophylaxis.

Key Concept

Infectious disease screening and prophylaxis protocols for patients initiating specific targeted biologic and immunomodulatory therapies are directly dictated by their mechanisms of immunosuppression.

Question 267Question →

Match each advanced biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD) with its most characteristic severe adverse effect or specific clinical contraindication.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Tocilizumab matches with increased risk of lower gastrointestinal perforation. Secukinumab matches with exacerbation of inflammatory bowel disease. Rituximab matches with PML and HBV reactivation. Tofacitinib matches with venous thromboembolism and herpes zoster risk. Abatacept matches with exacerbations in COPD.

Each targeted DMARD carries specific risks beyond general immunosuppression. Tocilizumab (IL-6 inhibitor) is uniquely associated with GI perforation, particularly in diverticular disease. Secukinumab (IL-17 inhibitor) can exacerbate or unmask IBD. Rituximab (anti-CD20) causes profound B-cell depletion, risking HBV reactivation and PML. Tofacitinib (JAK inhibitor) is associated with thrombosis, cardiovascular events, and shingles. Abatacept (T-cell costimulation modulator) worsens COPD symptoms.

Step-by-Step Solution

1

Identify the mechanism of action for each targeted DMARD.

Tocilizumab (anti-IL-6), Secukinumab (anti-IL-17A), Rituximab (anti-CD20), Tofacitinib (JAK inhibitor), Abatacept (CTLA4-Ig).

Understanding the precise immunologic target is necessary to predict pathway-specific toxicities.

2

Correlate each mechanism of action with its pathway-specific clinical consequences and FDA warnings.

IL-6 blockade impairs bowel integrity (perforation). IL-17 blockade triggers gut inflammation (IBD). CD20 depletion risks severe viral reactivation (HBV, JC virus). JAK inhibition alters lipid metabolism and coagulation (MACE, VTE) and VZV immunity. CTLA4-Ig exacerbates existing lung disease (COPD).

Accurately matching the drug to its unique severe adverse effect is critical for safe prescribing in rheumatology.

Key Concept

Adverse effect profiles and specific contraindications of non-TNF biologic and targeted synthetic DMARDs.

Estimated Time:2m 0s

Question 268Question →

A 68-year-old man is evaluated in the hospital on day 4 of admission for persistent low-grade fevers and fatigue. He originally presented with a 2-week history of generalized weakness, night sweats, and shortness of breath. His medical history is significant for hypertension and osteoarthritis. On examination today, temperature is 37.8°C (100.0°F), blood pressure is 128/76 mmHg, and pulse is 88/min. Cardiac auscultation reveals a new grade 3/6 holosystolic murmur heard best at the cardiac apex. Laboratory studies show a leukocyte count of 12,400/mm³ and serum creatinine of 1.4 mg/dL (baseline 0.9 mg/dL). Blood cultures drawn at admission have grown *Enterococcus faecalis* in 4 out of 4 bottles. Susceptibility testing demonstrates the isolate is susceptible to ampicillin, vancomycin, and linezolid, and lacks high-level aminoglycoside resistance. A transesophageal echocardiogram shows a 1.2-cm mobile vegetation on the mitral valve. The patient is currently receiving empiric therapy with intravenous vancomycin and cefepime. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Discontinue current antibiotics and initiate intravenous ampicillin and ceftriaxone

Continue both intravenous vancomycin and cefepime

Discontinue cefepime and continue intravenous vancomycin monotherapy

Discontinue current antibiotics and initiate intravenous daptomycin

Discontinue cefepime and add intravenous gentamicin to the vancomycin regimen

Show answer & explanation

Answer: Discontinue current antibiotics and initiate intravenous ampicillin and ceftriaxone

Answer

The correct step is to discontinue the broad-spectrum empiric antibiotics and initiate targeted therapy with intravenous ampicillin and ceftriaxone.

The most appropriate management is transitioning to intravenous ampicillin and ceftriaxone. *Enterococcus faecalis* endocarditis requires prolonged, bactericidal combination therapy. When the isolate is susceptible, ampicillin is the preferred beta-lactam backbone. Because ampicillin alone is only bacteriostatic against *Enterococcus*, synergy is required to achieve bactericidal activity for deep-seated infections. This synergy is traditionally achieved by adding an aminoglycoside (e.g., gentamicin) or a third-generation cephalosporin (ceftriaxone). In a patient with acute kidney injury (evidenced by a rising serum creatinine from 0.9 to 1.4 mg/dL), the ampicillin and ceftriaxone combination is highly preferred due to comparable efficacy and a significantly lower risk of nephrotoxicity. Discontinuing the empiric vancomycin and cefepime correctly follows antibiotic stewardship protocols by narrowing the spectrum of coverage.

Step-by-Step Solution

1

Interpret the clinical presentation, imaging, and laboratory data.

The patient has native-valve *Enterococcus faecalis* infective endocarditis, complicated by a mild acute kidney injury (elevated creatinine).

Four positive blood cultures, a new regurgitant murmur, and a valvular vegetation on echocardiography confirm the diagnosis. The rising creatinine establishes the renal impairment.

2

Determine the optimal antibiotic backbone based on susceptibility and stewardship principles.

Ampicillin must be selected as the primary agent.

De-escalating from broad-spectrum empiric therapy (vancomycin) to a targeted, narrow-spectrum agent (ampicillin) for susceptible organisms is a foundational rule of antibiotic stewardship.

3

Identify the need for bactericidal synergy and select the safest secondary agent.

Ceftriaxone is added to ampicillin instead of an aminoglycoside.

Ampicillin is only bacteriostatic against *Enterococcus*; endocarditis requires bactericidal synergy. While gentamicin provides synergy, ceftriaxone provides equal synergistic efficacy with significantly less nephrotoxicity, making it the drug of choice in patients with existing renal impairment.

Key Concept

De-escalation of empiric antibiotics to targeted synergistic therapy (ampicillin and ceftriaxone) for *Enterococcus faecalis* endocarditis, prioritizing nephron-sparing regimens in the setting of acute kidney injury.

Estimated Time:1m 30s

Question 269Question →

Match each clinical scenario describing a medication-specific toxicity, mechanism, or required screening protocol to the appropriate disease-modifying medication used in rheumatologic conditions.

Click a left item, then click its matching right item

Show answer & explanation

Answer

1 matches Hydroxychloroquine (maculopathy); 2 matches Leflunomide (cholestyramine washout); 3 matches Cyclophosphamide (acrolein-induced cystitis); 4 matches Adalimumab (TB reactivation); 5 matches Azathioprine (TPMT screening).

Proper management of rheumatologic conditions requires intimate knowledge of drug toxicities. Hydroxychloroquine causes dose-dependent retinopathy. Leflunomide inhibits pyrimidine synthesis and requires cholestyramine washout due to severe teratogenicity and a long half-life. Cyclophosphamide's metabolite acrolein causes hemorrhagic cystitis, preventable with mesna. Adalimumab, a TNF-alpha inhibitor, disrupts granulomas and risks TB reactivation. Azathioprine metabolism depends on TPMT, necessitating genetic screening to prevent fatal bone marrow suppression.

Step-by-Step Solution

1

Analyze each clinical vignette to identify the signature adverse effect, mechanism, or prerequisite screening requirement being described.

Identified toxicities/protocols: maculopathy/vision changes, teratogenicity requiring active washout, acrolein-induced hemorrhagic cystitis, latent tuberculosis reactivation, and TPMT-related myelosuppression.

Recognizing the signature side effects and monitoring requirements is essential for safely managing immunomodulatory therapies.

2

Correlate these clinical clues with the known pharmacologic profiles of common rheumatologic medications.

Maculopathy maps to hydroxychloroquine; the pyrimidine inhibitor requiring washout is leflunomide; acrolein toxicity maps to cyclophosphamide; TNF-alpha inhibition causing TB reactivation maps to adalimumab; and TPMT metabolism maps to azathioprine.

Matching the distinct pharmacologic characteristics to the clinical scenarios ensures accurate identification of the responsible disease-modifying antirheumatic drugs (DMARDs).

Key Concept

Monitoring requirements and adverse effect profiles of disease-modifying antirheumatic drugs (DMARDs) and immunosuppressants.

Question 270Question →

A $74$ -year-old man is admitted to the hospital with a four-week history of low-grade fevers, progressive fatigue, and an unintentional weight loss of $4\text{ kg}$ ( $8.8\text{ lbs}$ ). His medical history is significant for ischemic cardiomyopathy, type 2 diabetes mellitus, and a surgical aortic valve replacement with a bioprosthetic valve three years ago. His temperature is $38.2^\circ\text{C}$ ( $100.8^\circ\text{F}$ ), blood pressure is $122/76\text{ mmHg}$ , and pulse is $92/\text{min}$ . Physical examination reveals a grade 3/6 diastolic murmur at the right upper sternal border. Inspection of the hands reveals small, painless, erythematous macules on the palms. A transesophageal echocardiogram shows an oscillating $1.1\text{ cm}$ mass on the bioprosthetic aortic valve. Three sets of blood cultures grow gram-positive cocci in pairs and short chains that are catalase-negative and capable of growing in $6.5\%$ sodium chloride broth. Susceptibility testing indicates that the organism is susceptible to ampicillin, vancomycin, and daptomycin, but it exhibits high-level resistance to gentamicin and streptomycin. His serum creatinine is $1.9\text{ mg/dL}$ . Which of the following is the most appropriate targeted intravenous antibiotic regimen for this patient?

Ampicillin and gentamicin

Daptomycin monotherapy

Ampicillin and ceftriaxone

Vancomycin and gentamicin

Vancomycin and rifampin

Show answer & explanation

Answer: Ampicillin and ceftriaxone

Answer

The most appropriate regimen is intravenous ampicillin and ceftriaxone.

The correct answer is intravenous ampicillin and ceftriaxone. This patient's clinical presentation (prolonged fever, a new diastolic murmur indicating aortic regurgitation, and Janeway lesions on the palms) combined with the echocardiographic finding of a vegetation confirms the diagnosis of prosthetic valve infective endocarditis. The microbiological findings—catalase-negative, gram-positive cocci in pairs and short chains capable of growing in

6.5\%

sodium chloride—are classic for Enterococcus species (predominantly Enterococcus faecalis). Treatment of enterococcal endocarditis requires prolonged, bactericidal combination therapy. Historically, this synergy was achieved using a cell wall-active agent (e.g., ampicillin) combined with an aminoglycoside (e.g., gentamicin). However, this patient's isolate exhibits high-level gentamicin resistance (HLAR), which entirely abolishes the synergistic effect of the aminoglycoside. Adding gentamicin would be completely ineffective and would only introduce the risk of acute kidney injury, which is particularly dangerous given the patient's already elevated serum creatinine of

1.9\text{ mg/dL}

. The treatment of choice for HLAR E. faecalis endocarditis is the combination of ampicillin and ceftriaxone. This double beta-lactam therapy achieves bactericidal synergy because ampicillin and ceftriaxone saturate complementary penicillin-binding proteins (PBPs) on the bacterial cell membrane—ampicillin binds PBP4 and PBP5, while ceftriaxone binds PBP2 and PBP3.

Step-by-Step Solution

1

Identify the causative pathogen based on the provided microbiological characteristics.

The organism is identified as Enterococcus species (most likely Enterococcus faecalis).

Gram-positive cocci in pairs and short chains that are catalase-negative and grow in 6.5% NaCl broth are pathognomonic microbiological features of Enterococci.

2

Diagnose the clinical syndrome.

The patient has prosthetic valve infective endocarditis.

The clinical triad of prolonged fever, a new diastolic murmur (aortic regurgitation), and peripheral stigmata (Janeway lesions) alongside an echocardiographically confirmed vegetation confirms the diagnosis.

3

Analyze the susceptibility profile to determine the feasibility of traditional therapy.

The isolate is susceptible to ampicillin but has high-level aminoglycoside resistance (HLAR).

Enterococcal endocarditis requires bactericidal synergistic therapy. The historical standard of ampicillin plus gentamicin cannot be used because HLAR abolishes the synergistic effect of the aminoglycoside.

4

Select the appropriate alternative bactericidal synergistic regimen.

Intravenous ampicillin and ceftriaxone is selected.

This dual beta-lactam therapy provides excellent bactericidal synergy against Enterococcus faecalis by saturating different penicillin-binding proteins without requiring an aminoglycoside, which is especially important given the patient's elevated creatinine.

Key Concept

Management of Enterococcal endocarditis exhibiting high-level aminoglycoside resistance (HLAR)

Estimated Time:2m 0s

Question 271Question →

Pair each patient's key clinical findings with the most appropriate rheumatologic or vasculitic diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Headache and jaw claudication pairs with Giant cell arteritis; inflammatory back pain and uveitis pairs with Ankylosing spondylitis; sicca symptoms and parotid enlargement pairs with Sjögren syndrome; acute first MTP arthritis pairs with Gout.

Each patient vignette describes classic, pathognomonic features of common rheumatologic and vasculitic conditions, testing the fundamental ability to recognize these hallmark presentations.

Step-by-Step Solution

1

Evaluate the first vignette for classic vasculitis symptoms.

The symptoms align with temporal arteritis, which requires urgent recognition to prevent irreversible vision loss.

Identifying the classic triad in elderly patients points directly to the diagnosis.

2

Analyze the second vignette for characteristics of back pain.

The pain improves with exercise and is associated with extra-articular manifestations (uveitis), indicating an inflammatory etiology.

Differentiating inflammatory from mechanical back pain is the key step in diagnosing axial spondyloarthritis.

3

Assess the third vignette for characteristic exocrine gland dysfunction.

The dry eyes, dry mouth, and parotid swelling are identified as classic sicca syndrome.

These findings directly map to the primary clinical criteria for the condition.

4

Examine the fourth vignette for crystal arthropathy signs.

The severe, acute onset of pain in the great toe (podagra) is identified.

Podagra is the most common and specific initial presentation of this crystal arthropathy.

Key Concept

Recognition of classic clinical presentations of common rheumatologic and vasculitic diseases

Question 272Question →

During morning rounds on the general medical floor, a resident evaluates a newly admitted patient who presented overnight with chronic cough, progressive fatigue, and hemoptysis. The patient recently emigrated from a country with a high incidence of endemic respiratory pathogens. Vital signs reveal a temperature of $38.3^\circ\text{C}$ ( $100.9^\circ\text{F}$ ). Review of a portable chest radiograph obtained in the emergency department demonstrates a prominent cavitary opacity in the right upper lobe with surrounding consolidation. The clinical team strongly suspects active pulmonary tuberculosis.

Arrange the following clinical and infection control interventions in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence prioritizes infection control, followed by diagnostics, then initiation of empiric therapy, and finally the criteria for stepping down isolation.

The correct sequence begins with the most urgent public health intervention: airborne isolation. Once the environment is safe, the diagnostic sequence requires obtaining a sputum sample before starting drugs that could sterilize the sample or lower its diagnostic yield. After the sample is secured, empiric RIPE therapy is started immediately to treat the active infection. Finally, removing the patient from isolation is the last step in the acute timeline, requiring proof of non-infectiousness (three negative smears).

Step-by-Step Solution

1

Isolate the patient using airborne precautions.

The risk of healthcare-associated airborne transmission is mitigated.

Unrecognized or improperly isolated pulmonary tuberculosis is a major cause of nosocomial outbreaks. Infection control must precede all other interventions.

2

Collect sputum for AFB smear, mycobacterial culture, and NAAT.

Pathogen identification and initial drug-resistance testing are initiated.

Administering antimicrobial therapy prior to sample collection can reduce the yield of subsequent cultures. An initial sample should be obtained immediately.

3

Start empiric RIPE therapy (rifampin, isoniazid, pyrazinamide, ethambutol).

Mycobacterial replication is targeted and halted.

Because mycobacterial cultures take several weeks to grow, therapy must be initiated empirically in highly suspicious cases to prevent disease progression and reduce infectiousness.

4

Discontinue isolation once strict criteria are met.

The patient can be safely moved to a standard room.

Discontinuation of airborne precautions requires adherence to standard therapy, clinical improvement, and exactly three consecutive negative AFB sputum smears.

Key Concept

Management of highly suspicious active pulmonary tuberculosis must strictly follow a sequence of immediate airborne isolation, prompt microbiological sampling, empiric four-drug therapy, and maintained isolation until three consecutive negative smears are documented.

Question 273Question →

A 24-year-old primigravid woman at 26 weeks gestation is evaluated during a routine prenatal visit. She has no fatigue, dyspnea, or palpitations. Her pregnancy has been uncomplicated. She takes a daily prenatal multivitamin. Blood pressure is 112/70 mm Hg and pulse is 78/min. Physical examination shows a gravid uterus consistent with gestational age and no peripheral edema.

Laboratory results are as follows:

Test	Result
Hemoglobin	10.9 g/dL
Hematocrit	32%
Mean corpuscular volume	88 fL
White blood cell count	8,500/mm³
Platelet count	240,000/mm³
Serum ferritin	55 ng/mL

Which of the following is the most appropriate next step in the management of this patient's hematologic findings?

Reassurance and routine prenatal care

Initiation of high-dose oral ferrous sulfate

Measurement of serum methylmalonic acid

Peripheral blood smear evaluation

Hemoglobin electrophoresis

Show answer & explanation

Answer: Reassurance and routine prenatal care

Answer

Reassurance and routine prenatal care

The correct answer is reassurance and routine prenatal care because this patient's hematologic findings represent the normal physiologic changes of pregnancy. During pregnancy, plasma volume expands by approximately 40-50%, while red blood cell mass increases by only 20-30%. This disproportionate increase leads to a hemodilution effect, lowering the hemoglobin and hematocrit concentrations. In the first and third trimesters, the lower limit of normal for hemoglobin is 11.0 g/dL, while in the second trimester, it drops to 10.5 g/dL. Since this patient is at 26 weeks gestation (second trimester) with a hemoglobin of 10.9 g/dL, normal mean corpuscular volume (MCV), and normal ferritin, she does not have true iron deficiency anemia and requires no further intervention.

Step-by-Step Solution

1

Analyze the hemoglobin level in the context of the patient's gestational age.

The hemoglobin is 10.9 g/dL at 26 weeks gestation, which is within normal limits. The threshold for anemia in the second trimester is < 10.5 g/dL.

Pregnancy induces a disproportionate increase in plasma volume relative to red blood cell mass, leading to physiologic hemodilution.

2

Evaluate the iron stores and red blood cell indices to rule out true hematologic deficiency.

The serum ferritin is 55 ng/mL (normal) and the mean corpuscular volume is 88 fL (normal).

Iron deficiency is the most common cause of true anemia in pregnancy and must be differentiated from expected physiologic changes.

3

Determine the appropriate management plan based on the findings.

No additional hematologic intervention or diagnostic workup is required.

The patient is asymptomatic and exhibits a completely normal physiologic dilutional state.

Key Concept

Physiologic dilutional anemia of pregnancy occurs due to a greater expansion of plasma volume compared to red blood cell mass, resulting in an expected hemoglobin drop (minimum > 10.5 g/dL in the second trimester) without true iron deficiency.

Question 274Question →

Review the following clinical presentations of patients who develop complications during or shortly after receiving blood product transfusions. Match each patient's clinical scenario with the primary pathophysiologic mechanism responsible for their reaction.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches are: The 35-year-old with isolated fever matches cytokine accumulation (FNHTR). The 52-year-old with normal JVP and pulmonary infiltrates matches donor anti-leukocyte antibodies (TRALI). The 78-year-old with elevated JVP and S3 matches rapid volume expansion (TACO). The 24-year-old with flank pain and dark urine matches preformed recipient IgM (AHTR). The 29-year-old with immediate anaphylaxis matches recipient anti-IgA antibodies.

Each clinical vignette contains specific differentiating features that pinpoint the diagnosis. The timing (seconds vs hours), volume status (elevated vs normal JVP), and presence of end-organ damage (hemolysis, anaphylaxis) directly correlate with the five distinct pathophysiologic mechanisms of transfusion complications.

Step-by-Step Solution

1

Analyze the onset time and primary organ systems involved in each vignette.

Identifies the core syndrome: isolated fever vs. pulmonary edema vs. systemic hemolysis vs. anaphylaxis.

Transfusion reactions are heavily differentiated by the timing of onset and specific end-organ manifestations.

2

Differentiate the two pulmonary edema presentations by assessing volume status.

The patient with normal JVP has noncardiogenic edema (TRALI), while the patient with elevated JVP, hypertension, and an S3 has cardiogenic edema (TACO).

Both TRALI and TACO present with respiratory distress and bilateral infiltrates, making volume status indicators (JVP, blood pressure) the critical distinguishing factors.

3

Differentiate the acute febrile reactions by looking for signs of hemolysis.

The patient with clear urine and stable vitals has a simple febrile nonhemolytic reaction. The patient with dark urine, shock, and DIC has an acute hemolytic reaction.

Febrile nonhemolytic reactions are benign and self-limiting, whereas acute hemolytic reactions are life-threatening medical emergencies driven by complement-mediated erythrocyte destruction.

4

Map the identified clinical syndromes to their underlying immunologic or physiologic mechanisms.

Finalizes the pairings based on standard pathophysiologic pathways for FNHTR, TRALI, TACO, AHTR, and anaphylaxis.

Understanding the mechanism is essential for proper future prevention (e.g., leukoreduction for FNHTR, IgA-deficient blood products for anaphylaxis).

Key Concept

Clinical presentation and pathophysiology of major transfusion reactions

Question 275Question →

Match each patient's clinical presentation with the most likely causative pneumonia pathogen.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The sudden lobar pneumonia with rust-colored sputum matches Streptococcus pneumoniae. The pneumonia with diarrhea, confusion, and hyponatremia matches Legionella pneumophila. The indolent dry cough in a dormitory resident matches Mycoplasma pneumoniae. The pneumonia with currant jelly sputum in a patient with alcohol use disorder matches Klebsiella pneumoniae.

Each specific pneumonia pathogen has a distinct epidemiological profile and clinical presentation that sets it apart. Recognizing classic buzzwords such as 'rust-colored sputum', 'currant jelly sputum', or the association of pneumonia with 'diarrhea and hyponatremia' allows for rapid identification of the most likely organism.

Step-by-Step Solution

1

Analyze the demographic and historical clues in each clinical vignette.

Identified key risk factors: assisted living (elderly), travel/convention, dormitory living, and alcohol use disorder.

Different pneumonia pathogens have strong epidemiological associations with specific patient populations and exposures.

2

Identify defining clinical and laboratory features for each presentation.

Noted specific features: rust-colored sputum, watery diarrhea with hyponatremia, indolent dry cough with interstitial infiltrates, and thick blood-tinged 'currant jelly' sputum.

Pathognomonic signs and symptoms help differentiate among the common causes of community-acquired and atypical pneumonia.

3

Correlate the distinct clinical profiles with the correct organisms.

Successfully paired each presentation to its classic causative bacteria.

This confirms mastery of pattern recognition for common infectious diseases as required on board examinations.

Key Concept

Classic clinical and epidemiological associations in community-acquired pneumonia.

Question 276Question →

A 62-year-old woman is evaluated on postoperative day 6 following a right total knee arthroplasty. Since the surgery, she has been receiving subcutaneous unfractionated heparin for deep vein thrombosis prophylaxis. Today, she reports new-onset left calf pain and swelling.

Vital signs are within normal limits. Physical examination reveals left calf tenderness, erythema, and 2+ pitting edema up to the knee.

Laboratory studies on admission:
Hemoglobin: 13.2 g/dL
Leukocyte count: 8,500/mm³
Platelet count: 260,000/mm³

Laboratory studies today:
Hemoglobin: 12.8 g/dL
Leukocyte count: 9,200/mm³
Platelet count: 110,000/mm³

A duplex ultrasonography of the left lower extremity demonstrates a noncompressible popliteal vein. Which of the following is the most appropriate next step in management?

Discontinue unfractionated heparin and initiate argatroban

Discontinue unfractionated heparin and initiate warfarin

Switch unfractionated heparin to enoxaparin

Transfuse irradiated pooled platelets

Continue unfractionated heparin and obtain a CT pulmonary angiogram

Show answer & explanation

Answer: Discontinue unfractionated heparin and initiate argatroban

Answer

Discontinue unfractionated heparin and initiate argatroban

This patient's presentation of a >50% drop in platelets occurring 5-10 days after heparin initiation, combined with a new deep vein thrombosis, is highly suggestive of type 2 heparin-induced thrombocytopenia (HIT). HIT is an immune-mediated disorder caused by antibodies against heparin-platelet factor 4 (PF4) complexes, which activate platelets and create a profound prothrombotic state. The most critical next step is to immediately discontinue all heparin products and initiate non-heparin anticoagulation, such as a direct thrombin inhibitor (e.g., argatroban, bivalirudin) or an indirect factor Xa inhibitor (e.g., fondaparinux).

Step-by-Step Solution

1

Calculate the 4T score for Heparin-Induced Thrombocytopenia.

The patient has a platelet count drop of >50% (2 points), timing between days 5 and 10 (2 points), new thrombosis (2 points), and no other clear cause (2 points), yielding a high probability score.

To determine the pretest probability of HIT before changing therapy.

2

Determine the immediate management for high-probability HIT.

Stop the offending agent (heparin) and start a direct thrombin inhibitor (argatroban).

Continuing heparin worsens the thrombosis, and untreated HIT carries a high risk of catastrophic thrombotic events.

Key Concept

Diagnosis and management of Heparin-Induced Thrombocytopenia (HIT)

Question 277Question →

A 12-year-old boy is evaluated in the pediatric office for his annual health maintenance visit. He was born full-term at 39 weeks of gestation following an uncomplicated pregnancy. His vital parameters include a temperature of $37.0^\circ\text{C}$ ( $98.6^\circ\text{F}$ ), heart rate of 82/min, and blood pressure of 108/68 mm Hg. The physical assessment is entirely within normal limits, and he is meeting all expected psychosocial and academic milestones. His immunization record is current. As part of comprehensive preventive care, the attending physician audits the patient's historical medical chart to verify that all age-appropriate universal screening tests were conducted. Place the following universal pediatric screening interventions in the chronological order in which they are routinely recommended to occur, starting with the earliest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of universal pediatric screenings from earliest to most recent is: 1. Critical congenital heart disease screening (Newborn), 2. Autism-specific screening (18 months), 3. Objective visual acuity with optotypes (4 years), 4. Universal dyslipidemia screening (9-11 years), 5. Universal depression screening (12 years).

Routine well-child care involves specific screening milestones aimed at early disease detection. According to the AAP, screening for critical congenital heart disease (CCHD) using pulse oximetry is universally performed in the newborn nursery prior to discharge. Autism-specific screening using standardized questionnaires (like the M-CHAT) is explicitly recommended at the 18-month and 24-month visits. Objective visual acuity testing using optotypes (e.g., Snellen chart) begins at age 4, when children can reliably follow the testing instructions. Universal lipid screening is recommended to occur once between the ages of 9 and 11 to establish a baseline before pubertal lipid changes occur. Finally, universal screening for adolescent depression using self-report tools begins at age 12.

Step-by-Step Solution

1

Identify the recommended age for critical congenital heart disease (CCHD) screening.

Newborn period (24-48 hours of life).

Early detection via pulse oximetry is critical before the ductus arteriosus fully closes, preventing sudden cardiovascular collapse.

2

Identify the recommended age for autism-specific screening.

First administered universally at 18 months of age.

This timing coincides with critical developmental windows for identifying deficits in social communication, allowing for early intervention.

3

Identify the recommended age for objective visual acuity testing with optotypes.

Typically begins at 4 years of age.

By age 4, most children have the cognitive development and attention span required to reliably identify standardized shapes or letters on a vision chart to detect amblyopia.

4

Identify the recommended age for universal dyslipidemia screening.

Performed between 9 and 11 years of age.

Screening is completed during this window to obtain an accurate lipid baseline before the normal physiologic lipid alterations associated with puberty occur.

5

Identify the recommended age for universal adolescent depression screening.

Begins at 12 years of age.

The incidence of major depressive disorder increases significantly during early adolescence, making this the optimal time to begin annual self-reported universal screening.

Key Concept

Universal pediatric screening timeline according to the American Academy of Pediatrics (AAP) Bright Futures guidelines.

Question 278Question →

A $28$ -year-old primigravida at $32$ weeks gestation presents to the emergency department reporting acute-onset fatigue, shortness of breath, and dark urine for the past $24$ hours. $3$ days ago, she was diagnosed with an uncomplicated urinary tract infection and prescribed nitrofurantoin. Her prenatal course has otherwise been unremarkable.

Temperature is $37.4^\circ\text{C}$ ( $99.3^\circ\text{F}$ ), blood pressure is $110/70$ mmHg, pulse is $112$ /min, and respirations are $20$ /min. Physical examination reveals conjunctival pallor and mild scleral icterus. The uterine fundus is consistent with gestational age. Continuous fetal heart rate monitoring demonstrates a baseline of $165$ /min, minimal variability, and occasional variable decelerations.

Laboratory studies show:

Test	Result	Reference Range
Hemoglobin	$6.8$ g/dL	$11.0$ - $14.0$ g/dL
Platelets	$185,000/\mu\text{L}$	$150,000$ - $400,000/\mu\text{L}$
Leukocytes	$9,500/\mu\text{L}$	$4,500$ - $11,000/\mu\text{L}$
Mean corpuscular volume	$94$ fL	$80$ - $100$ fL
Lactate dehydrogenase	$840$ U/L	$100$ - $250$ U/L
Total bilirubin	$4.5$ mg/dL	$0.1$ - $1.2$ mg/dL
Direct bilirubin	$0.5$ mg/dL	$0.0$ - $0.3$ mg/dL
Aspartate aminotransferase	$25$ U/L	$10$ - $40$ U/L
Alanine aminotransferase	$22$ U/L	$7$ - $56$ U/L
Creatinine	$0.7$ mg/dL	$0.5$ - $1.1$ mg/dL

A peripheral blood smear stained with Wright-Giemsa is obtained (see image) and reveals scattered erythrocytes with irregular, semi-circular marginal defects.

Which of the following is the most appropriate next step in management?

Initiate intravenous piperacillin-tazobactam and admit to the intensive care unit

Reassure the patient and prescribe oral iron supplementation for physiologic anemia

Discontinue the current antibiotic and prepare for packed red blood cell transfusion

Proceed directly to emergent cesarean delivery for non-reassuring fetal status

Order a comprehensive thyroid panel including thyroid-stimulating hormone

Show answer & explanation

Answer: Discontinue the current antibiotic and prepare for packed red blood cell transfusion

Answer

Discontinue the current antibiotic and prepare for packed red blood cell transfusion.

The correct answer involves discontinuing the offending medication and providing a blood transfusion. The patient is experiencing acute hemolytic anemia due to Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, triggered by the recent initiation of nitrofurantoin. This is evidenced by her acute drop in hemoglobin, elevated indirect bilirubin, elevated lactate dehydrogenase, and the classic peripheral smear finding of degmacytes (bite cells). In G6PD deficiency, oxidative stress causes hemoglobin to denature into Heinz bodies, which are subsequently 'bitten' out by splenic macrophages. The symptomatic anemia (tachycardia, dyspnea) and non-reassuring fetal status are secondary to decreased maternal oxygen carrying capacity. The most appropriate next step is to stop the offending agent and provide a blood transfusion to restore oxygen delivery, which simultaneously acts as intrauterine resuscitation for the fetus.

Step-by-Step Solution

1

Analyze the clinical presentation and laboratory data to identify the primary pathophysiologic process.

The patient has acute severe normocytic anemia, elevated lactate dehydrogenase, indirect hyperbilirubinemia, and hemoglobinuria (dark urine), indicating an acute hemolytic crisis.

Recognizing the presence of active hemolysis is the critical first step before determining the specific etiology.

2

Correlate the hemolytic crisis with the patient's recent medical history and peripheral smear findings.

The recent initiation of nitrofurantoin combined with the presence of degmacytes (bite cells) on the peripheral smear confirms oxidative stress-induced hemolysis, which is characteristic of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Identifying the specific trigger is necessary to halt the disease process and guide targeted management.

3

Evaluate the maternal and fetal clinical status to determine the urgency and type of intervention required.

The mother is symptomatic (tachycardia, dyspnea) with a critically low hemoglobin of

6.8

g/dL, leading to secondary fetal compromise (fetal tachycardia, minimal variability).

Fetal distress in this context is secondary to maternal hypoxia; thus, maternal resuscitation is the absolute priority.

4

Select the most appropriate definitive management.

Discontinue the oxidative drug (nitrofurantoin) and administer a packed red blood cell transfusion to correct the oxygen-carrying deficit.

Stopping the offending agent halts further hemolysis, while a blood transfusion treats the severe symptomatic anemia and serves as effective intrauterine resuscitation.

Key Concept

Diagnosis and management of acute hemolytic anemia due to Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, including the recognition of oxidative triggers and the provision of appropriate supportive care.

Estimated Time:2m 0s

Question 279Question →

A group of patients presents to the emergency department with signs and symptoms of lower respiratory tract infection. Based on the unique clinical features described for each patient, match the clinical presentation with the most likely causative pathogen.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The hotel guest with hyponatremia has Legionella pneumophila; the college student with interstitial infiltrates has Mycoplasma pneumoniae; the patient with alcohol use disorder and cavitary lesion has Klebsiella pneumoniae; and the patient with abrupt rust-colored sputum has Streptococcus pneumoniae.

Each specific clinical vignette contains classic 'buzzword' clues that reliably map to a specific bacterial etiology of pneumonia, allowing for targeted empiric therapy and appropriate diagnostic testing.

Step-by-Step Solution

1

Identify key epidemiologic risk factors for each patient.

Hotel stay suggests Legionella, dormitory living suggests Mycoplasma, and alcohol use disorder suggests Klebsiella.

Many pneumonia pathogens have strong associations with specific exposures or patient demographics.

2

Analyze systemic symptoms and laboratory abnormalities.

Diarrhea and hyponatremia strongly point toward Legionella. Insidious onset with a dry cough suggests an atypical organism like Mycoplasma.

Extrapulmonary symptoms help differentiate typical from atypical pneumonias.

3

Evaluate radiographic and sputum characteristics.

Upper lobe cavitation with thick sputum indicates Klebsiella. Rust-colored sputum with lobar consolidation indicates Streptococcus pneumoniae.

Specific pathogens cause distinct patterns of lung tissue destruction and exudate formation.

Key Concept

Pathogen-specific clinical, epidemiologic, and laboratory features of community-acquired pneumonia.

Estimated Time:1m 0s

Question 280Question →

Match each pediatric clinical scenario involving an infectious disease exposure or risk with the most appropriate preventive management step.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The scenarios correctly match as follows: The newborn exposed to Hepatitis B requires both the Hepatitis B vaccine and HBIG; the unimmunized 5-year-old exposed to chickenpox receives the varicella vaccine for post-exposure prophylaxis; the 4-week-old exposed to pertussis requires macrolide antibiotic prophylaxis; and the 8-month-old traveling to a measles-endemic area requires an early, non-counting MMR dose.

Each clinical scenario requires a specific, guideline-directed preventive measure based on the patient's age, exposure type, and immunization status. Hepatitis B perinatal exposure requires active and passive immunity (Vaccine + HBIG). Varicella exposure in unimmunized, immunocompetent children over 1 year of age is managed with the varicella vaccine. Pertussis exposure necessitates macrolide prophylaxis for all household contacts. International travel for infants 6-11 months of age requires an early MMR dose to provide immediate, albeit temporary, protection.

Step-by-Step Solution

1

Evaluate the newborn exposed to maternal Hepatitis B.

Identify the need for both active and passive immunity.

Perinatal transmission risk is extremely high, necessitating immediate dual prophylaxis within 12 hours of delivery.

2

Assess the 5-year-old exposed to chickenpox.

Determine eligibility for varicella post-exposure prophylaxis.

Administration of the varicella vaccine within 3 to 5 days of exposure is highly effective at preventing or modifying the disease in unimmunized, healthy children.

3

Analyze the 4-week-old exposed to a sibling with pertussis.

Select macrolide antibiotic prophylaxis.

Infants are at the highest risk for severe pertussis morbidity; all household contacts require post-exposure antibiotic prophylaxis regardless of their current vaccination status.

4

Consider the 8-month-old traveling internationally to a measles outbreak region.

Recommend an early MMR vaccination dose.

Infants 6 to 11 months old are at significant risk during international travel and should receive an early, non-counting MMR dose to ensure temporary immunity.

Key Concept

Post-exposure prophylaxis and specialized preventive immunization strategies in pediatric populations.

Estimated Time:1m 0s

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept